Literature DB >> 3359113

Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart.

R Y Man1.   

Abstract

1. The tissue level of lysophosphatidylcholine (LPC) was determined in rat hearts perfused with a solution containing 5 microM LPC. The relationship between LPC accumulation and the severity of arrhythmias produced was examined. 2. The accumulation of LPC was dependent on the perfusion time and this accumulation was associated with the occurrence of severe arrhythmias. A positive correlation between the tissue LPC content and the arrhythmia score was found (P less than 0.01). 3. No consistent alteration in total phospholipid, phosphatidylcholine or cholesterol content was found. This suggests that LPC-induced arrhythmias are not associated with alterations of major lipid components in the heart. 4. When severe arrhythmias occurred in the presence of LPC in the rat perfused heart, less than 2% of total tissue phospholipid was in the form of LPC. 5. The positive correlation between LPC accumulation and the occurrence of arrhythmias suggests a cause and effect relationship of LPC with cardiac arrhythmias in the rat perfused heart. However, in the ischaemic heart, other biochemical factors can contribute, to different degrees, to ischaemia-induced cardiac arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3359113      PMCID: PMC1853811          DOI: 10.1111/j.1476-5381.1988.tb11448.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

2.  Alterations in lysophosphatidylcholine levels of canine heart: modes of extraction and storage.

Authors:  T Mock; M P Pelletier; R Y Man; P C Choy
Journal:  Anal Biochem       Date:  1984-03       Impact factor: 3.365

3.  Pathophysiological concentrations of lysophosphatides and the slow response.

Authors:  P B Corr; D W Snyder; B I Lee; R W Gross; C R Keim; B E Sobel
Journal:  Am J Physiol       Date:  1982-08

4.  Lysophosphatidylcholine causes cardiac arrhythmia.

Authors:  R Y Man; P C Choy
Journal:  J Mol Cell Cardiol       Date:  1982-03       Impact factor: 5.000

5.  Incorporation of radiolabeled lysophosphatidyl choline into canine Purkinje fibers and ventricular muscle. Electrophysiological, biochemical, and autoradiographic correlations.

Authors:  R W Gross; P B Corr; B I Lee; J E Saffitz; W A Crafford; B E Sobel
Journal:  Circ Res       Date:  1982-07       Impact factor: 17.367

6.  The effects of lysophosphatidylcholine, a toxic metabolite of ischemia, on the components of cardiac excitability in sheep Purkinje fibers.

Authors:  M F Arnsdorf; G J Sawicki
Journal:  Circ Res       Date:  1981-07       Impact factor: 17.367

7.  Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis.

Authors:  N A Shaikh; E Downar
Journal:  Circ Res       Date:  1981-08       Impact factor: 17.367

8.  Phosphatidylcholine formation from exogenous lysophosphatidylcholine in isolated hamster heart.

Authors:  J D Savard; P C Choy
Journal:  Biochim Biophys Acta       Date:  1982-04-15

9.  Potential arrhythmogenic electrophysiological derangements in canine Purkinje fibers induced by lysophosphoglycerides.

Authors:  P B Corr; M E Cain; F X Witkowski; D A Price; B E Sobel
Journal:  Circ Res       Date:  1979-06       Impact factor: 17.367

10.  Alterations of phospholipids in ischemic canine myocardium during acute arrhythmia.

Authors:  R Y Man; T L Slater; M P Pelletier; P C Choy
Journal:  Lipids       Date:  1983-10       Impact factor: 1.880

View more
  8 in total

1.  Differential effects of lysophosphatidylcholine and ACh on muscarinic K(+),non-selective cation and Ca(2+) currents in guinea-pig atrial cells.

Authors:  Libing Li; Isao Matsuoka; Kazuho Sakamoto; Junko Kimura
Journal:  Fukushima J Med Sci       Date:  2016-02-25

2.  Cell membrane-derived lysophosphatidylcholine activates cardiac ryanodine receptor channels.

Authors:  Yuki Nakamura; Midori Yasukochi; Sei Kobayashi; Kiyoko Uehara; Akira Honda; Ryuji Inoue; Issei Imanaga; Akira Uehara
Journal:  Pflugers Arch       Date:  2006-10-07       Impact factor: 3.657

3.  The association of lysophosphatidylcholine with isolated cardiac myocytes.

Authors:  R Y Man; A A Kinnaird; I Bihler; P C Choy
Journal:  Lipids       Date:  1990-08       Impact factor: 1.880

4.  Phospholipid alterations in the brain and heart in a rat model of asphyxia-induced cardiac arrest and cardiopulmonary bypass resuscitation.

Authors:  Junhwan Kim; Joshua W Lampe; Tai Yin; Koichiro Shinozaki; Lance B Becker
Journal:  Mol Cell Biochem       Date:  2015-07-10       Impact factor: 3.396

5.  Potential mechanisms for the enhancement of HERG K+ channel function by phospholipid metabolites.

Authors:  Jingxiong Wang; Yiqiang Zhang; Huizhen Wang; Hong Han; Stanley Nattel; Baofeng Yang; Zhiguo Wang
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

6.  Examination of physiological function and biochemical disorders in a rat model of prolonged asphyxia-induced cardiac arrest followed by cardio pulmonary bypass resuscitation.

Authors:  Junhwan Kim; Tai Yin; Ming Yin; Wei Zhang; Koichiro Shinozaki; Mary A Selak; Kirk L Pappan; Joshua W Lampe; Lance B Becker
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 7.  Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.

Authors:  Atsushi Yamashita; Yasuhiro Hayashi; Naoki Matsumoto; Yoko Nemoto-Sasaki; Takanori Koizumi; Yusuke Inagaki; Saori Oka; Takashi Tanikawa; Takayuki Sugiura
Journal:  Biology (Basel)       Date:  2017-03-30

8.  Antigen-induced generation of lyso-phospholipids in human airways.

Authors:  F H Chilton; F J Averill; W C Hubbard; A N Fonteh; M Triggiani; M C Liu
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.